Related Experiment Video
Updated: Apr 5, 2026

An Enrichment Method for Small Extracellular Vesicles Derived from Liver Cancer Tissue
Published on: February 3, 2023
Exosomes: A Promising Factor Involved in Cancer Hypoxic Microenvironments
1Department of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, China. sunxinchen2012@163.com.
Hypoxia (low oxygen) in tumors drives cancer progression and drug resistance, with exosomes playing a key role. These tiny vesicles carry signals that promote tumor growth and can serve as biomarkers for early cancer detection.
Area of Science:
- Oncology
- Cell Biology
- Biochemistry
Background:
- Hypoxia is a critical tumor characteristic influencing cancer progression, malignancy, and therapeutic resistance.
- Exosomes, small extracellular vesicles, are key mediators of intercellular communication and are implicated in cancer adaptive processes.
- Hypoxia significantly enhances the secretion of exosomes, which carry functional biomolecules.
Purpose of the Study:
- To elucidate the role of exosomes in hypoxia-driven cancer progression.
- To explore the potential of exosomes as biomarkers for hypoxia status in tumors.
- To highlight the therapeutic implications of targeting exosome-mediated communication in cancer.
Main Methods:
- Review of existing literature on hypoxia, exosomes, and cancer biology.
- Analysis of exosome biogenesis and secretion under hypoxic conditions.
- Investigation of exosome cargo (nucleic acids, proteins) and their functional impact.
Main Results:
- Hypoxia stimulates exosome release, facilitating tumor cell adaptation and resistance.
- Exosomes mediate intercellular communication, influencing tumor microenvironment components like cancer-associated fibroblasts and angiogenesis.
- Exosomal content reflects donor cell characteristics, positioning them as potential biomarkers for hypoxia.
Conclusions:
- Exosomes are crucial mediators of hypoxia-induced tumor progression, heterogeneity, and drug resistance.
- Exosomes hold promise as minimally invasive biomarkers for diagnosing and monitoring cancer hypoxia.
- Targeting exosome pathways presents a potential therapeutic strategy for hypoxic cancers.
Related Concept Videos
The Tumor Microenvironment
The Tumor Microenvironment
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Regulation of Angiogenesis and Blood Supply

